The FDA warns against using bone-growth proteins in patients under 18 who have bone growth defects, citing the risk of excess bone growth and other potential problems.
The FDA this week warned healthcare providers against using 2 types of bone-growth materials in patients under age 18 who have bone growth defects.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yzhLbx
Cap comentari:
Publica un comentari a l'entrada